Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gross

Showing results (331-340 of 336) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 336 results.
The Lancet Regional Health. Europe|July 17, 2025
Rurality, travel distance, and effectiveness of remote patient management in patients with heart failure in the TIM-HF2 trial in Germany: a pre-specified analysis of an open-label, randomised controlled trialFabian Kerwagen, Stefan Störk, Kerstin Koehler, et al.
ACS Nano|February 12, 2025
Piezoresistive Platinum Diselenide Pressure Sensors with Reliable High Sensitivity and Their Integration into Complementary Metal-Oxide-Semiconductor CircuitsSebastian Lukas, Nico Rademacher, Sofía Cruces, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2007
A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the ratMichael F Jarvis, Prisca Honore, Char-Chang Shieh, et al.
Journal of the American College of Cardiology|September 1, 2024
Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2Piotr Ponikowski, Tim Friede, Ralph Stephan von Bardeleben, et al.
European Journal of Heart Failure|June 7, 2024
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trialsStefan D Anker, Tim Friede, Ralph Stephan von Bardeleben, et al.
The New England Journal of Medicine|August 31, 2024
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral RegurgitationStefan D Anker, Tim Friede, Ralph-Stephan von Bardeleben, et al.
Pageof 34

Showing results (331-340 of 336) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 336 results.
The Lancet Regional Health. Europe|July 17, 2025
Rurality, travel distance, and effectiveness of remote patient management in patients with heart failure in the TIM-HF2 trial in Germany: a pre-specified analysis of an open-label, randomised controlled trialFabian Kerwagen, Stefan Störk, Kerstin Koehler, et al.
ACS Nano|February 12, 2025
Piezoresistive Platinum Diselenide Pressure Sensors with Reliable High Sensitivity and Their Integration into Complementary Metal-Oxide-Semiconductor CircuitsSebastian Lukas, Nico Rademacher, Sofía Cruces, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2007
A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the ratMichael F Jarvis, Prisca Honore, Char-Chang Shieh, et al.
Journal of the American College of Cardiology|September 1, 2024
Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2Piotr Ponikowski, Tim Friede, Ralph Stephan von Bardeleben, et al.
European Journal of Heart Failure|June 7, 2024
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trialsStefan D Anker, Tim Friede, Ralph Stephan von Bardeleben, et al.
The New England Journal of Medicine|August 31, 2024
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral RegurgitationStefan D Anker, Tim Friede, Ralph-Stephan von Bardeleben, et al.
Pageof 34